137 related articles for article (PubMed ID: 6387757)
1. Variable clinical response to choline in tardive dyskinesia.
Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
Davis KL; Berger PA
Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
[TBL] [Abstract][Full Text] [Related]
3. Oral choline administration to patients with tardive dyskinesia.
Growdon JH; Hirsch MJ; Wurtman RJ; Wiener W
N Engl J Med; 1977 Sep; 297(10):524-7. PubMed ID: 887103
[TBL] [Abstract][Full Text] [Related]
4. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
Gelenberg AJ; Doller-Wojcik JC; Growdon JH
Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic influences in tardive dyskinesia.
Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
[TBL] [Abstract][Full Text] [Related]
7. CDP-choline for the treatment of tardive dyskinesia: a small negative series.
Gelenberg AJ; Wojcik J; Falk WE; Bellinghausen B; Joseph AB
Compr Psychiatry; 1989; 30(1):1-4. PubMed ID: 2647398
[TBL] [Abstract][Full Text] [Related]
8. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Quinn N; Marsden CD
J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
[TBL] [Abstract][Full Text] [Related]
9. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
Greil W; Auberger S; Haag H; Rüther E
Neuropsychobiology; 1985; 14(1):17-22. PubMed ID: 3906426
[TBL] [Abstract][Full Text] [Related]
10. Treatment of tardive dyskinesia with choline and tetrabenazine.
Snell AP; Cleary M; Sambrook M
Postgrad Med J; 1980 Sep; 56(659):663-4. PubMed ID: 7465478
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Jeste DV; Wyatt RJ
Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
[TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
Berger PA; Rexroth K
Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic treatments for tardive dyskinesia.
Alphs LD; Davis JM
Mod Probl Pharmacopsychiatry; 1983; 21():168-86. PubMed ID: 6140629
[No Abstract] [Full Text] [Related]
16. [Therapeutic measures in tardive dyskinesia].
Tegeler J; Wöller W
Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
[TBL] [Abstract][Full Text] [Related]
17. Choline in tardive dyskinesia and Huntington's disease.
Davis KL; Hollister LE; Barchas JD; Berger PA
Life Sci; 1976 Nov; 19(10):1507-15. PubMed ID: 136581
[No Abstract] [Full Text] [Related]
18. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
[TBL] [Abstract][Full Text] [Related]
19. Effects of choline on tardive dyskinesia and other movement disorders.
Growdon JH
Psychopharmacol Bull; 1978 Oct; 14(4):55-6. PubMed ID: 151871
[No Abstract] [Full Text] [Related]
20. Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia.
Huang CC; Wang RI; Hasegawa A; Alverno L
Psychopharmacology (Berl); 1981; 73(4):359-62. PubMed ID: 6789358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
